FILE PHOTO: A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
(Reuters) - U.S. Food and Drug Administration (FDA) staff said on Tuesday that data on Pfizer Inc's coronavirus vaccine was in line with its guidance on emergency use authorization, raising hopes it could soon be available to Americans aged 16 and above.
The comments were made in documents released ahead of Thursday's meeting of outside experts to discuss whether the shot developed with German partner BioNTech SE should be authorized for emergency use. (https://bit.ly/3ov6eYr)
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
